Gossamer Bio, Inc. (GOSS)
0.3465
-0.03
(-7.55%)
USD |
NASDAQ |
Mar 27, 16:00
0.355
+0.01
(+2.45%)
After-Hours: 20:00
Gossamer Bio Shareholders Equity (Quarterly) : -122.76M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 327.19M |
| Madrigal Pharmaceuticals, Inc. | 602.69M |
| Artelo Biosciences, Inc. | -1.272M |
| Axsome Therapeutics, Inc. | 88.30M |
| Crinetics Pharmaceuticals, Inc. | 992.08M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 172.25M |
| Total Liabilities (Quarterly) | 295.01M |
| Debt to Equity Ratio | -1.653 |
| Current Ratio | 2.643 |
| Net Debt Paydown Yield | 0.02% |